(IMMR) Immersion - Ratings and Ratios
Haptic Software, Patents, Licensing, Automotive Touch, Gaming
EPS (Earnings per Share)
Revenue
Dividends
| Dividend Yield | 6.64% |
| Yield on Cost 5y | 5.27% |
| Yield CAGR 5y | 50.00% |
| Payout Consistency | 100.0% |
| Payout Ratio | 30.2% |
| Risk via 5d forecast | |
|---|---|
| Volatility | 39.0% |
| Value at Risk 5%th | 57.8% |
| Relative Tail Risk | -9.95% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -0.57 |
| Alpha | -36.73 |
| CAGR/Max DD | -0.01 |
| Character TTM | |
|---|---|
| Hurst Exponent | 0.228 |
| Beta | 1.068 |
| Beta Downside | 0.899 |
| Drawdowns 3y | |
|---|---|
| Max DD | 55.70% |
| Mean DD | 26.78% |
| Median DD | 25.32% |
Description: IMMR Immersion October 28, 2025
Immersion Corporation (NASDAQ:IMMR) is a Florida-based IP licensor that monetizes its patented haptic-feedback technology across a broad set of end-markets-including mobile devices, wearables, gaming consoles, automotive infotainment, and medical equipment-by providing software SDKs, integration tools, and technical support to OEMs and developers worldwide.
Key recent data points: (1) FY 2024 licensing revenue grew ~12% YoY to roughly $70 million, reflecting expanding adoption in smartphones and AR/VR headsets; (2) the global haptic-technology market is projected to reach $13 billion by 2028, driven by rising consumer demand for immersive experiences and automotive safety-system integration; (3) Immersion’s top licensees now include Samsung, Sony, and Tesla, indicating concentration of revenue among a few large partners, which amplifies both upside potential and counter-party risk.
If you want a data-rich, third-party perspective on how Immersion’s valuation stacks up against sector peers, a quick look at ValueRay’s analyst framework can help you spot any pricing gaps before you dive deeper.
Piotroski VR‑10 (Strict, 0-10) 5.0
| Net Income (90.2m TTM) > 0 and > 6% of Revenue (6% = 74.1m TTM) |
| FCFTA -0.06 (>2.0%) and ΔFCFTA -15.82pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue 31.38% (prev 451.5%; Δ -420.1pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA -0.06 (>3.0%) and CFO -77.8m <= Net Income 90.2m (YES >=105%, WARN >=100%) |
| Net Debt (244.5m) to EBITDA (177.2m) ratio: 1.38 <= 3.0 (WARN <= 3.5) |
| Current Ratio 1.72 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (33.1m) change vs 12m ago 1.06% (target <= -2.0% for YES) |
| Gross Margin 29.08% (prev 98.97%; Δ -69.89pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 155.6% (prev 15.72%; Δ 139.9pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio 16.19 (EBITDA TTM 177.2m / Interest Expense TTM 9.62m) >= 6 (WARN >= 3) |
Altman Z'' 3.33
| (A) 0.28 = (Total Current Assets 926.0m - Total Current Liabilities 538.6m) / Total Assets 1.37b |
| (B) 0.03 = Retained Earnings (Balance) 41.7m / Total Assets 1.37b |
| (C) 0.20 = EBIT TTM 155.6m / Avg Total Assets 793.1m |
| (D) 0.05 = Book Value of Equity 43.7m / Total Liabilities 804.2m |
| Total Rating: 3.33 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 67.31
| 1. Piotroski 5.0pt |
| 2. FCF Yield -22.35% |
| 3. FCF Margin -6.96% |
| 4. Debt/Equity 1.01 |
| 5. Debt/Ebitda 1.38 |
| 6. ROIC - WACC (= 16.54)% |
| 7. RoE 33.99% |
| 8. Rev. Trend 75.41% |
| 9. EPS Trend 21.52% |
What is the price of IMMR shares?
Over the past week, the price has changed by +6.08%, over one month by +1.49%, over three months by -6.62% and over the past year by -19.03%.
Is IMMR a buy, sell or hold?
- Strong Buy: 1
- Buy: 1
- Hold: 0
- Sell: 0
- Strong Sell: 0
What are the forecasts/targets for the IMMR price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 13.5 | 98.5% |
| Analysts Target Price | 13.5 | 98.5% |
| ValueRay Target Price | 7 | 3.1% |
IMMR Fundamental Data Overview December 26, 2025
P/E Trailing = 3.5944
P/E Forward = 16.0256
P/S = 1.3886
P/B = 0.6912
P/EG = -0.45
Beta = 0.879
Revenue TTM = 1.23b USD
EBIT TTM = 155.6m USD
EBITDA TTM = 177.2m USD
Long Term Debt = 141.2m USD (from longTermDebt, last quarter)
Short Term Debt = 74.5m USD (from shortTermDebt, last quarter)
Debt = 322.1m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 244.5m USD (from netDebt column, last quarter)
Enterprise Value = 384.4m USD (216.1m + Debt 322.1m - CCE 153.9m)
Interest Coverage Ratio = 16.19 (Ebit TTM 155.6m / Interest Expense TTM 9.62m)
FCF Yield = -22.35% (FCF TTM -85.9m / Enterprise Value 384.4m)
FCF Margin = -6.96% (FCF TTM -85.9m / Revenue TTM 1.23b)
Net Margin = 7.31% (Net Income TTM 90.2m / Revenue TTM 1.23b)
Gross Margin = 29.08% ((Revenue TTM 1.23b - Cost of Revenue TTM 875.3m) / Revenue TTM)
Gross Margin QoQ = 22.29% (prev 24.46%)
Tobins Q-Ratio = 0.28 (Enterprise Value 384.4m / Total Assets 1.37b)
Interest Expense / Debt = 1.29% (Interest Expense 4.17m / Debt 322.1m)
Taxrate = 47.27% (17.4m / 36.8m)
NOPAT = 82.1m (EBIT 155.6m * (1 - 47.27%))
Current Ratio = 1.72 (Total Current Assets 926.0m / Total Current Liabilities 538.6m)
Debt / Equity = 1.01 (Debt 322.1m / totalStockholderEquity, last quarter 319.2m)
Debt / EBITDA = 1.38 (Net Debt 244.5m / EBITDA 177.2m)
Debt / FCF = -2.85 (negative FCF - burning cash) (Net Debt 244.5m / FCF TTM -85.9m)
Total Stockholder Equity = 265.4m (last 4 quarters mean from totalStockholderEquity)
RoA = 6.58% (Net Income 90.2m / Total Assets 1.37b)
RoE = 33.99% (Net Income TTM 90.2m / Total Stockholder Equity 265.4m)
RoCE = 38.27% (EBIT 155.6m / Capital Employed (Equity 265.4m + L.T.Debt 141.2m))
RoIC = 20.94% (NOPAT 82.1m / Invested Capital 391.8m)
WACC = 4.40% (E(216.1m)/V(538.3m) * Re(9.95%) + D(322.1m)/V(538.3m) * Rd(1.29%) * (1-Tc(0.47)))
Discount Rate = 9.95% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 33.33 | Cagr: 0.45%
Fair Price DCF = unknown (Cash Flow -85.9m)
EPS Correlation: 21.52 | EPS CAGR: -17.67% | SUE: -0.18 | # QB: 0
Revenue Correlation: 75.41 | Revenue CAGR: 206.0% | SUE: 4.0 | # QB: 3
EPS next Year (2025-12-31): EPS=0.64 | Chg30d=-0.230 | Revisions Net=-1 | Growth EPS=-76.0% | Growth Revenue=+88.4%
Additional Sources for IMMR Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle